EdwardMPeresMD
Hematology • Detroit, MIHematologic Oncology
Associate Professor Hematology Oncology Stem CellTransplant, Cellular Therapy Internal Medicine, Henry Ford Hospital Wayne State Universty
Dr. Peres is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2799 W Grand Blvd
Ste K13
Detroit, MI 48202Phone+1 313-916-5002
Education & Training
Detroit Medical CenterBone Marrow Transplant , 2003 - 2004
Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 2000 - 2003- Children's Hospital of MichiganResidency, Pediatrics, 1997 - 2000
Ross University School of MedicineClass of 1997
Certifications & Licensure
MI State Medical License 2000 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
- Trial Of Double Umbilical Cord Blood Transplantation Start of enrollment: 2008 Dec 01
- Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies Start of enrollment: 2010 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsMycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecyclineEdward Peres, Yasser Khaled, Oleg I. Krijanovski, Shin Mineishi, John E. Levine
Transplant Infectious Disease. 2009-02-01 - 42 citationsThalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplantMuneer H. Abidi, Isaacson Tove, Rami B. Ibrahim, Dan Maria, Edward Peres
American Journal of Hematology. 2007-10-01 - 198 citationsIncreasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, Marcelo C. Pasquini, Michael Martens, Ruta Brazauskas, Xiaochun Zhu
Blood. 2017-08-31
Press Mentions
Henry Ford Cancer Institute Treats Its First Patient with Innovative 'Living Drug' TherapyJune 18th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
